Salix Pharmaceuticals Ltd. (SLXP) Income Statement

Income Statement for Salix Pharmaceuticals Ltd.  (SLXP) 
$ 48.18   -0.71 (-1.45%) Volume: 3.48 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 48.18 0.00 (0.00%) Volume: 839  4:50 PM EST Feb 10, 2012
Statement: View:
Income [+] in Thousands of Dollars
12/2010 12/2009 12/2008 12/2007 12/2006
Operating Revenue 336,973 232,890 178,766 235,792 208,533
Total Revenue 336,973 232,890 178,766 235,792 208,533
Adjustments to Revenue - - - - -
Cost of Revenue (90,264) (46,470) (32,998) (54,859) (39,878)
Cost of Sales With Depreciation 68,677 52,025 36,710 56,874 41,443
Gross Margin 246,709 186,420 145,768 180,933 168,655
Gross Operating Profit 246,709 186,420 145,768 180,933 168,655
Selling/General/Admin Expense (156,101) (120,020) (95,088) (86,492) (83,932)
Research & Development (73,346) (89,466) (83,735) (71,947) (47,917)
Advertising - - - - -
EBITDA (Operating Income Before Depreciation) 17,262 (23,066) (33,055) 22,494 36,806
Depreciation & Amortization (23,439) (17,040) (13,603) (10,642) (6,472)
Depreciation, Unreconciled - - - - -
Amortization - - - - -
Amortization of Intangibles 45,026 11,485 9,891 8,627 4,907
Operating Income (6,177) (40,106) (46,658) 11,852 30,334
Operating Profit After Depreciation (6,177) (40,106) (46,658) 11,852 30,334
Interest Income 2,626 1,221 2,035 3,326 2,552
Earnings from Equity Interest - - - - -
Other Income, Net - - - - -
Income, Acquired in Process R&D - - - - -
Income, Restructuring and M&A - - - - -
Other Special Charges - - - - -
Total Income Before Interest Expense (EBIT) (3,551) (38,885) (44,623) 15,178 32,886
Interest Expense (20,652) (6,746) (3,100) - -
Income Before Tax (24,203) (45,631) (47,723) 15,178 32,886
Income Taxes (2,858) 2,012 116 (6,953) (1,376)
Minority Interest - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Other Special Charges (24,203) (45,631) (47,723) 15,178 32,886
Net Income from Continuing Operations (27,061) (43,619) (47,607) 8,225 31,510
Net Income from Discontinued Operations - - - - -
Net Income from Total Operations (27,061) (43,619) (47,607) 8,225 31,510
Normalized Income (27,061) (43,619) (47,607) 8,225 31,510
Extraordinary Income/Loss - - - - -
Special Income/Charges - - - - -
Income from Cum. Effect of Acct Change - - - - -
Income from Tax Loss Carryforward - - - - -
Net Income Available for Common (27,061) (43,619) (47,607) 8,225 31,510
Other Gains - - - - -
Total Net Income (27,061) (43,619) (47,607) 8,225 31,510
Net Income Available for Common (27,061) (43,619) (47,607) 8,225 31,510
Results [+] in Dollars (Preferred Dividends in Thousands)
12/2010 12/2009 12/2008 12/2007 12/2006
Dividends Paid Per Share 0.00 0.00 0.00 0.00 0.00
Preferred Dividends - - - - -
Basic EPS from Continuing Operations -0.47 -0.88 -0.99 0.17 0.68
Basic EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Basic EPS from Extraordinary Income Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Basic EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Total Net Income -0.47 -0.88 -0.99 0.17 0.68
Basic Normalized Net Income per Share -0.47 -0.88 -0.99 0.17 0.68
Basic EPS from Total Operations -0.47 -0.88 -0.99 0.17 0.68
Diluted EPS from Continuing Operations -0.47 -0.88 -0.99 0.17 0.65
Diluted EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Extraordinary Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Total Net Income -0.47 -0.88 -0.99 0.17 0.65
Diluted Normalized Net Income per Share -0.47 -0.88 -0.99 0.17 0.65
Excise Tax - - - - -
Diluted EPS from Total Operations -0.47 -0.88 -0.99 0.17 0.65
 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.